𝔖 Bobbio Scriptorium

✦ LIBER ✦

Registry of Lipid Control and the Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan: Rationality and Methods

✍ Scribed by Yin, Wei-Hsian; Wu, Chau-Chung; Chen, Jaw-Wen

Book ID: 119261832
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 144 KB
Volume: 6
Category: Article
ISSN: 1873-9598
DOI: 10.1016/j.ijge.2012.09.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma Triglycerides and Cardiovascular

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

✍ Ole Faergeman; Ingar Holme; Rana Fayyad; Sonal Bhatia; Scott M. Grundy; John J.P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Influence and Critique of the JUPITER Tr

Influence and Critique of the JUPITER Trial (Statins v No Statins for Primary Prevention of Cardiovascular Events in Patients with Normal Lipids and Elevated C-Reactive Protein)

✍ Russell H. Samson; Deepak G. Nair 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Evaluation of a novel antiplatelet agent

Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial

✍ David A. Morrow; Benjamin M. Scirica; Keith A.A. Fox; Gail Berman; John Strony; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Incidence and Predictors of Angioedema i

Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

✍ Linda B. Piller; Charles E. Ford; Barry R. Davis; Chuke Nwachuku; Henry R. Black 📂 Article 📅 2006 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 229 KB

Impact of Smoking on Cardiovascular Even

Impact of Smoking on Cardiovascular Events in Patients With Coronary Disease Receiving Contemporary Medical Therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trials)

✍ Paul Frey; David D. Waters; David A. DeMicco; Andrei Breazna; Larry Samuels; And 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 475 KB

PCV169 ACETYLSALICYLIC ACID(ASA) MONOTHE

PCV169 ACETYLSALICYLIC ACID(ASA) MONOTHERAPY FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: AN ASSESSMENT OF THE MEDICAL BENEFIT USING THE IQWIG METHODOLOGICAL APPROACH

✍ S Maxion-Bergemann; F Hessel; ES Dietrich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB